🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to determine whether, in patients wit...
Status
Completed
Location
Cedars-Sinai Heart Institute
Start Date
2017-03-02
Trial ID
NCT02816736
Treatments Being Tested
To characterize the safety, tolerability, and efficacy profile of amlodipin...
Status
Completed
Location
Novartis Investigative site
Start Date
2008-05
Trial ID
NCT00699192
Treatments Being Tested
The purpose of this study is to look at the differences in how individuals ...
Status
Enrolling By Invitation
Location
Mayo Clinic in Rochester
Start Date
2022-11-04
Trial ID
NCT05279742
Treatments Being Tested
This study assessed the efficacy and safety of the valsartan/amlodipine 160...
Status
Completed
Location
Investigative site in Romainia
Start Date
2009-09
Trial ID
NCT01001572
Treatments Being Tested
This study is a prospective monocentric, randomized, double-blind, placebo-...
Status
Terminated
Location
Montreal Heart Institute
Start Date
2022-03-15
Trial ID
NCT05117736
Treatments Being Tested
The pathophysiological implications of various cancer diseases and anti-can...
Status
Completed
Location
University Hospital Essen
Start Date
2022-12-12
Trial ID
NCT05636774
Treatments Being Tested
This is a phase IV, prospective, randomized, double-blind, double-dummy, pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-07-05
Trial ID
NCT03300427
Treatments Being Tested
SYH9056 tablets are a combination of valsartan and levamlodipine maleate. T...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-24
Trial ID
NCT06771245
Treatments Being Tested
To assess efficacy, safety and tolerability of valsartan when comparing two...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11-08
Trial ID
NCT01617681
Treatments Being Tested
Obese individuals have a higher prevalence of nocturnal hypertension and no...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-02-18
Trial ID
NCT04971720
Treatments Being Tested